Alfred Penfornis

7.7k total citations
170 papers, 3.7k citations indexed

About

Alfred Penfornis is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Alfred Penfornis has authored 170 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 125 papers in Endocrinology, Diabetes and Metabolism, 52 papers in Surgery and 33 papers in Genetics. Recurrent topics in Alfred Penfornis's work include Diabetes Management and Research (85 papers), Diabetes Treatment and Management (66 papers) and Pancreatic function and diabetes (39 papers). Alfred Penfornis is often cited by papers focused on Diabetes Management and Research (85 papers), Diabetes Treatment and Management (66 papers) and Pancreatic function and diabetes (39 papers). Alfred Penfornis collaborates with scholars based in France, United States and Switzerland. Alfred Penfornis's co-authors include Pierre‐Yves Benhamou, Sophie Borot, G. Charpentier, Sylvia Franc, Charles Thivolet, P.Y. Benhamou, É. Eschwège, Martin Schlumberger, Eric Baudin and Dured Dardari and has published in prestigious journals such as The Journal of Immunology, Gastroenterology and PLoS ONE.

In The Last Decade

Alfred Penfornis

153 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alfred Penfornis France 35 2.0k 1.3k 679 556 466 170 3.7k
Gaurav Agarwal India 33 1.4k 0.7× 1.9k 1.4× 547 0.8× 403 0.7× 594 1.3× 250 4.9k
Limin Peng United States 34 2.3k 1.2× 757 0.6× 880 1.3× 347 0.6× 813 1.7× 103 4.4k
Konstantinos P. Economopoulos United States 34 601 0.3× 1.6k 1.2× 339 0.5× 355 0.6× 821 1.8× 102 3.5k
S Tudy G Roup 8 1.1k 0.5× 2.5k 1.9× 271 0.4× 316 0.6× 248 0.5× 17 4.1k
Anneke C. Muller Kobold Netherlands 37 746 0.4× 641 0.5× 298 0.4× 557 1.0× 588 1.3× 123 3.5k
Haipeng Xiao China 32 992 0.5× 538 0.4× 243 0.4× 307 0.6× 1.3k 2.7× 178 3.7k
Nihal Thomas India 28 910 0.5× 703 0.5× 449 0.7× 391 0.7× 443 1.0× 241 3.0k
Arthur W. Zieske United States 23 683 0.3× 975 0.7× 272 0.4× 606 1.1× 529 1.1× 58 3.9k
Hiroshi Noto Japan 25 1.4k 0.7× 554 0.4× 202 0.3× 433 0.8× 1.1k 2.3× 78 3.0k
Diana Bull United Kingdom 32 854 0.4× 507 0.4× 1.4k 2.1× 592 1.1× 759 1.6× 49 5.6k

Countries citing papers authored by Alfred Penfornis

Since Specialization
Citations

This map shows the geographic impact of Alfred Penfornis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alfred Penfornis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alfred Penfornis more than expected).

Fields of papers citing papers by Alfred Penfornis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alfred Penfornis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alfred Penfornis. The network helps show where Alfred Penfornis may publish in the future.

Co-authorship network of co-authors of Alfred Penfornis

This figure shows the co-authorship network connecting the top 25 collaborators of Alfred Penfornis. A scholar is included among the top collaborators of Alfred Penfornis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alfred Penfornis. Alfred Penfornis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Penfornis, Alfred, et al.. (2025). Long-Term Patterns in Automated Insulin Delivery and Carbohydrate Announcement: A 24-Month Follow-Up. Diabetes Technology & Therapeutics. 28(1). 83–87.
2.
Penfornis, Alfred, et al.. (2025). Hybrid Closed Loop in Adolescents and Young Adults Living with Type 1 Diabetes: A Real-World Study. Diabetes Technology & Therapeutics. 27(9). 760–764. 1 indexed citations
3.
4.
Baron, S., Jacques Beltrand, Sophie Borot, et al.. (2024). Transition from Paediatric to Adult Diabetes Care in People with Type 1 Diabetes: An Online Survey from France. Diabetes Therapy. 15(10). 2211–2222.
5.
Petit, Catherine, et al.. (2024). Precision medicine in type 1 diabetes: comparing metabolic outcomes of Control‐ IQ and MiniMed 780G according to patient characteristics. Diabetes Obesity and Metabolism. 27(3). 1233–1241. 3 indexed citations
6.
Gourdy, Pierre, Patrice Darmon, Isabelle Borget, et al.. (2024). Basal Insulinotherapy in Patients Living with Diabetes in France: The EF-BI Study. Diabetes Therapy. 15(6). 1349–1360.
7.
Penfornis, Alfred, et al.. (2023). European Survey on Adult People With Type 1 Diabetes and Their Caregivers: Insights into Perceptions of Technology. Journal of Diabetes Science and Technology. 19(2). 407–414. 1 indexed citations
8.
Lopes, Philippe, et al.. (2023). Impact of Intensive Glycemic Treatment on Diabetes Complications—A Systematic Review. Pharmaceutics. 15(7). 1791–1791. 15 indexed citations
9.
Lejeune, Marie, et al.. (2023). Closed-Loop Insulin Delivery Systems for People with Type 1 Diabetes and Chronic Very Poor Metabolic Control: It Works and Is Safe!. Diabetes Technology & Therapeutics. 26(2). 125–129. 3 indexed citations
10.
Boureau, Anne‐Sophie, Béatrice Guyomarch, Pierre Gourdy, et al.. (2023). Nocturnal hypoglycemia is underdiagnosed in older people with insulin‐treated type 2 diabetes: The HYPOAGE observational study. Journal of the American Geriatrics Society. 71(7). 2107–2119. 11 indexed citations
11.
Darmon, Patrice, B. Bauduceau, L. Bordier, et al.. (2021). Prise de position de la Société Francophone du Diabète (SFD) sur les stratégies d’utilisation des traitements anti-hyperglycémiants dans le diabète de type 2 – 2021. Médecine des Maladies Métaboliques. 15(8). 781–801. 3 indexed citations
12.
Franc, Sylvia, H. Hanaire, Pierre‐Yves Benhamou, et al.. (2020). DIABEO System Combining a Mobile App Software With and Without Telemonitoring Versus Standard Care: A Randomized Controlled Trial in Diabetes Patients Poorly Controlled with a Basal-Bolus Insulin Regimen. Diabetes Technology & Therapeutics. 22(12). 904–911. 20 indexed citations
13.
Franc, Sylvia, Michaël Joubert, C. Fagour, et al.. (2019). Efficacy of two telemonitoring systems to improve glycaemic control during basal insulin initiation in patients with type 2 diabetes: The TeleDiab‐2 randomized controlled trial. Diabetes Obesity and Metabolism. 21(10). 2327–2332. 23 indexed citations
14.
Brath, Helmut, Alfred Penfornis, Ignacio Conget, et al.. (2014). Real life effectiveness and safety of vildagliptin compared with other OADs in European type 2 diabetes mellitus patients: results from the EDGE study. Diabetologia. 57. 1 indexed citations
15.
Dejager, S., Alfred Penfornis, Jean‐Frédéric Blickle, B. Fiquet, & Stéphane Quéré. (2014). How are patients with type 2 diabetes and renal disease monitored and managed? Insights from the observational OREDIA study. Vascular Health and Risk Management. 10. 341–341. 27 indexed citations
16.
Penfornis, Alfred. (2011). Performance of a New Reusable Insulin Pen. Diabetes Technology & Therapeutics. 13(3). 373–379. 10 indexed citations
17.
Penfornis, Alfred, et al.. (2011). Current insulin therapy in patients with type 2 diabetes: Results of the ADHOC survey in France. Diabetes & Metabolism. 37(5). 440–445. 16 indexed citations
18.
Boini, Stéphanie, A. Fagot‐Campagna, Mounir Mesbah, et al.. (2009). Health related quality of life reference values (DHP) in people with diabetes living in France - Entred study, 2001-2003.. 368–371. 3 indexed citations
19.
Andrès, Axel, Philippe Morel, P.Y. Benhamou, et al.. (2005). Logistics and Transplant Coordination Activity in the GRAGIL Swiss-French Multicenter Network of Islet Transplantation. Transplantation. 79(9). 1200–1205. 48 indexed citations
20.
Penfornis, Alfred. (2003). Observance médicamenteuse dans le diabète de type 2 : influence des modalités du traitement médicamenteux et conséquences sur son efficacité. Diabetes & Metabolism. 29(2). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gaurav Agarwal Breakdown of academic impact, for papers by Limin Peng Breakdown of academic impact, for papers by Konstantinos P. Economopoulos Breakdown of academic impact, for papers by S Tudy G Roup Breakdown of academic impact, for papers by Anneke C. Muller Kobold Breakdown of academic impact, for papers by Haipeng Xiao Breakdown of academic impact, for papers by Nihal Thomas Breakdown of academic impact, for papers by Arthur W. Zieske Breakdown of academic impact, for papers by Hiroshi Noto Breakdown of academic impact, for papers by Diana Bull
Rankless by CCL
2026